Essentra (LON:ESNT – Get Free Report)‘s stock had its “buy” rating restated by Berenberg Bank in a research report issued on Thursday, MarketBeat Ratings reports. They presently have a GBX 200 ($2.60) price target on the stock. Berenberg Bank’s price objective would indicate a potential upside of 30.72% from the stock’s previous close.
A number of other equities research analysts have also recently issued reports on the company. Jefferies Financial Group reduced their price objective on Essentra from GBX 260 ($3.38) to GBX 250 ($3.25) and set a “buy” rating for the company in a report on Friday, July 12th. Deutsche Bank Aktiengesellschaft dropped their price target on Essentra from GBX 240 ($3.12) to GBX 200 ($2.60) and set a “buy” rating for the company in a report on Tuesday, September 17th.
Check Out Our Latest Stock Analysis on Essentra
Essentra Stock Performance
Insiders Place Their Bets
In related news, insider Scott Fawcett acquired 10,479 shares of the stock in a transaction on Wednesday, September 18th. The shares were purchased at an average price of GBX 142 ($1.84) per share, for a total transaction of £14,880.18 ($19,319.89). Company insiders own 0.99% of the company’s stock.
About Essentra
Essentra plc manufactures and distributes plastic injection and vinyl dip moulded, and metal components worldwide. The company offers cable ties and conduit, and accessories; grommets, strain relief, and blanking plugs; cable glands and accessories; caps and plugs; card guides and pullers; circuit board hardware products; EMI suppression ferrite cores; fan accessories comprising filters and fan mounting accessories; screws and nuts; rivet and panel fasteners; barbed and push-fit fasteners; binder screws and snap fasteners; washers; spacers; brushes; feet; fibre management; and furniture fittings.
See Also
- Five stocks we like better than Essentra
- NYSE Stocks Give Investors a Variety of Quality Options
- Texas Roadhouse Stock Steering for New Highs This Year
- Profitably Trade Stocks at 52-Week Highs
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Are Penny Stocks a Good Fit for Your Portfolio?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Essentra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Essentra and related companies with MarketBeat.com's FREE daily email newsletter.